Closer Than You Think – Or Not: Exploring the Impact of Bird Flu on Personal and Global Health in 2025

By Dr. J.E. Williams | 9th January 2025 | Reading Time: 14 minutes

In today’s interconnected world, the threat of infectious diseases looms large. One such menace that continues to haunt global health is bird flu. With its ability to rapidly spread across borders, infectious disease experts inform us that this highly contagious avian influenza virus poses a significant risk to humans and animals. But does it? This article delves into the rising threat of H5N1 and discusses H5N2, the new bird flu, and their potential impact on personal and global health.

What is bird flu? 

Bird flu, also known as avian influenza, is caused by certain Influenza A strains that primarily infect wild and domestic birds. However, some of these strains can jump from birds to mammals, including humans, leading to severe illness and, in some cases, even death. The rapid spread of bird flu is attributed to international travel, trade, and the proximity between humans and farmed animals raised in extremely crowded conditions. 

So far, it has only infected a few humans, but the impact on animals has been devastating. Wild bird deaths are in the millions, and 26 mammal species were also infected, including killing tens of thousands of seals from Canada to Peru. This epidemic is the worst bird flu outbreak in wildlife on record. 

While the world continues to grapple with the ongoing COVID-19 pandemic, understanding the impact of bird flu on global health is paramount. Join me as I delve into the latest research, explore preventive measures, and illuminate the potential consequences of this real viral threat.

Understanding H5N1/2 viruses

First identified in the late 1990s, H5N1, a subtype of the influenza A virus, drew attention because of its high mortality rate among seabirds and potential to cause widespread animal outbreaks and deaths. H5N1 and H5N2, the newest variant, are classified as zoonotic viruses, meaning they can jump from animals to humans, a characteristic that poses significant challenges for public health authorities worldwide. Let’s take a closer look and see how it may affect you. 

Avian influenza type A viruses cause bird flu. There are two subtypes based on the proteins on the surface of the virus: Hemagglutinin (HA), of which there are sixteen known subtypes (H1-H16), and Neuraminidase (NA), of which there are nine subtypes (N1-N9). Many combinations of HA and NA proteins are possible, like H5N1 and H5N2.

The virus primarily resides in the intestinal tract of infected birds. Wild waterfowl are considered natural reservoirs. From wild birds, it can spread to backyard chicken coups or commercial poultry farms.

Transmission of the bird flu involves direct contact with infected birds or their droppings. Wild birds often mingle with farmed poultry, scavenging for feed, spreading the infection to domestic birds, and making poultry workers vulnerable. The virus can also spread to an intermediary animal host, like pigs, or with H5N1 to dairy cows, then to human farm workers. 

Unique characteristics of the biological structure of the H5N1 virus allow it to evade the immune response in both birds and humans. Its ability to mutate and reassort with other influenza viral strains further complicates the situation, as new, more transmissible, or virulent variants can emerge. 

While most human cases were linked to contact with infected poultry or dairy cows, the potential for human-to-human transmission, though infrequent, remains a critical concern for epidemiologists and health officials because of its pandemic potential. So far, this has not occurred. 

However, it can be a severe disease. H5N1 case fatalities in infected humans were more than 50%. Since 2022, there have been dozens of cases of H5N1 infection in the U.S. and Canada—symptoms of human illness range from none to mild illness to severe disease and death. The World Health Organization recorded 948 cases of H5N1 in twenty years between 2003 and 2024, with 464 deaths. 

However, a new version, H5N2, is gaining ground. Recent studies have indicated that H5N2 is not only a threat to birds but is also capable of causing severe respiratory illness in humans, with a case fatality rate estimated at close to 70%. This alarming statistic highlights the need for robust surveillance and renewed research efforts to track the evolution of the virus to prevent a pandemic with a high death rate. 

The H5N2 virus belongs to the same family as the most notorious strains of the avian influenza virus. Although it primarily affects birds, it is capable of infecting humans. The first human death from H5N2 infection was a 50-year-old Mexican man who died in a hospital in Mexico City in June 2024. 

As we explore the historical outbreaks and global ramifications of H5N1 and H5N2, it becomes evident that a better understanding of its biology is crucial for developing effective control measures and improved personal prevention. It’s also important not to get caught in pandemic fear. 

Historical outbreaks of bird flu

Influenza viruses have infected animals and humans since ancient times. Wild waterfowl are an infectious reservoir that spreads the virus to barnyard poultry. From there, it jumps to domestic animals and then humans. Typically, bird flu doesn’t cause disease in wild birds. However, H5N2 caused a massive die-off among wild birds, including pelicans, ducks, terns, and other seabirds. And it spread to sea mammals, causing deaths in seals and sea lions.

Researchers trace bird flu outbreaks back to the early 20th century, but H5N1 did not emerge as a significant threat until the late 1990s. The first recorded outbreak in humans occurred in Hong Kong in 1997 when six infected people resulted in 18 human cases and six deaths. This outbreak marked a turning point, prompting the immediate culling of poultry and heightened surveillance measures. The swift response underscored the urgency with which health authorities act when faced with a potential zoonotic disease.

Following the original outbreak, H5N1 re-emerged in various regions, particularly China and Southeast Asia. From 2003 onward, the virus spread rapidly across countries, affecting domestic poultry populations and leading to numerous human infections. Vietnam, Thailand, and Indonesia were among the hardest-hit nations, with cases linked to close contact with infected birds. The World Health Organization (WHO) monitored the situation closely, issuing guidelines for prevention and control while emphasizing the importance of public awareness.

As the virus continued circulating, sporadic human cases occurred worldwide, leading to increased vigilance and research into the virus’s transmission dynamics. Notably, a 2004 outbreak in Vietnam resulted in a significant rise in human infections, prompting global health organizations to strengthen their response strategies. The experience gained from these outbreaks has been instrumental in shaping current public health policies to mitigate the risk of future pandemics. 

So far, the current N5N2 strain has only infected a few humans and killed one. The first confirmed death was of a Mexican man in the State of Mexico on May 23, 2024. The CDC reported 64 human infections in the United States. However, so far, there has been no person-to-person spread and no other deaths. Though the CDC considers the current bird flu low risk to humans, I advise vigilance and prevention. 

Global impact of bird flu on human health

The global impact of bird flu on human health is multifaceted, affecting those directly infected and broader public health systems and economies. As H5N1 and other avian influenza strains continue to pose threats, the potential for large-scale outbreaks and pandemics becomes more concerning. Although rare, human cases of previous bird flu outbreaks have had high mortality rates. Therefore, the specter of a mutated strain capable of efficient human-to-human transmission with a high death rate looms over global health discussions.

Public health responses to bird flu outbreaks have highlighted the need for rapid identification and containment of cases. Countries have developed emergency response plans, including stockpiling antiviral medications and establishing protocols for culling infected birds and mammals. However, the disparities in healthcare infrastructure between nations can significantly affect the ability to manage outbreaks effectively. Low-income countries may struggle with inadequate resources, making them more vulnerable to the consequences of avian influenza. 

Moreover, the psychological impact of bird flu outbreaks is significant. Fear of infection can lead to social stigma against those involved in poultry and dairy farming and can contribute to economic downturns in affected regions. Public health campaigns to educate communities about prevention and control measures are crucial in reducing fear and misinformation, ultimately fostering a more resilient response to future outbreaks.

Economic consequences of bird flu

The economic consequences of bird flu outbreaks extend far beyond the immediate costs associated with culling infected poultry. The poultry industry, a vital source of income and food for millions, often suffers devastating losses during outbreaks. Farmers face the dual burden of losing their livestock and dealing with the market fallout as consumer confidence plummets. In regions heavily reliant on poultry farming, such as Southeast Asia, the economic ripple effects can profoundly affect families, communities, and national economies.

Trade restrictions imposed during outbreaks further exacerbate economic challenges. Countries may ban the import of poultry and poultry products from affected regions, leading to significant financial losses for exporters. The interconnectedness of global trade means that an outbreak in one country can have repercussions across borders, impacting supply chains and international markets. The economic fallout from bird flu can also lead to job losses in related sectors, including processing, transportation, and retail.

Since implementing preventive measures and surveillance programs can incur substantial costs and have direct economic impacts, governments and organizations must invest in biosecurity measures to protect poultry populations and monitor potential outbreaks. These include developing bird vaccines, enhancing laboratory testing capacities, and conducting public awareness campaigns. While such investments are essential for long-term control, they can also strain national budgets, particularly in developing countries. 

Preventive measures against bird flu

Preventive measures against bird flu are crucial in mitigating the risks associated with this viral threat. Effective strategies begin with robust biosecurity practices on farms, which include controlling access to poultry areas, maintaining cleanliness, and ensuring that farmed birds keep away from wild birds that may carry the virus. Farmers are encouraged to implement strict measures to monitor the health of their flocks and report any unusual symptoms immediately to local authorities. These proactive steps can help detect and contain outbreaks before they escalate.

Public health campaigns play a vital role in educating communities about the risks of bird flu and the importance of adequately handling poultry products. Awareness should focus on safe cooking practices, emphasizing that thoroughly cooking poultry and eggs can eliminate the virus. Additionally, educating the public about the signs of bird flu in wild birds and farmed poultry can encourage timely reporting and intervention, essential for controlling potential outbreaks.

Avian influenza surveillance and monitoring

Avian influenza surveillance and monitoring are fundamental components of global health efforts to control the spread of bird flu. Surveillance systems aim to detect outbreaks early, allowing for a rapid response to prevent the virus from spreading to humans and other animals. Effective surveillance involves monitoring domestic and wild bird populations, as wild birds are known carriers of the virus and can contribute to its transmission.

Collaboration between governments, international organizations, and researchers is essential for establishing comprehensive surveillance networks. These networks enable sharing of data and resources, facilitating a coordinated response to outbreaks. For instance, the Global Early Warning System for Major Animal Diseases, launched by the Food and Agriculture Organization (FAO), aims to strengthen surveillance capabilities in vulnerable regions. By enhancing data collection and analysis, countries can better understand the dynamics of avian influenza and respond more effectively.

Moreover, technological advancements have revolutionized surveillance efforts. Molecular diagnostics, remote sensing, and data analytics allow for more rapid and accurate detection of avian influenza strains. By integrating these technologies into surveillance programs, public health authorities can identify potential hotspots for outbreaks and allocate resources more efficiently. Continued investment in surveillance and monitoring is essential for staying ahead of the evolving threat of avian influenza.

Do vaccination strategies for birds make sense?

Poultry vaccination is another measure that has shown promise in reducing the spread of avian influenza. However, it’s a controversial topic in the U.S. and the EU. Researchers developed vaccines to protect domestic birds from specific virus strains, including H5N1. Vaccination programs may significantly reduce the incidence of infection in poultry populations, thus lowering the risk of transmission to humans. 

However, the effectiveness of vaccines can be influenced by the virus’s ability to mutate, necessitating ongoing research and adaptation of vaccine strategies. The European Union has approved two H5N2 vaccines for chickens. Field trials are in progress in the United States, but no animal vaccines are approved. The vaccine choice depends on the specific strain of the virus prevalent in a region, with H5N1 vaccines being among the most widely used, but that can change, rendering vaccines useless.

One of the challenges in developing effective vaccination strategies for domestic poultry is the virus’s ability to mutate. Ongoing research is necessary to ensure that vaccines remain effective against emerging strains. However, vaccination alone is insufficient. Robust biosecurity measures help assure effectiveness in keeping flocks healthy. For instance, unvaccinated birds should stay in secure environments to prevent exposure to wild birds that may carry the virus.

Another critical aspect of vaccination strategies is public acceptance. Many are concerned about the immunological consequences of overuse of vaccines. Public health officials can educate farmers and poultry producers about the benefits of vaccination and risks and provide access to vaccines. Outreach efforts should emphasize the importance of immunization for protecting individual flocks and safeguarding public health. However, vaccination is limited in effect and bears heavy immunological consequences. By fostering a culture of healthier farming within the poultry industry, countries can enhance overall resilience against avian influenza. By working together, nations can create a unified front against this persistent threat to global health that is less dependent on vaccines.

Human bird flu vaccines 

There are no human vaccines for avian influenza A(H5N1). Three H5 flu vaccines were developed and licensed in 2007, 2013, and 2020 but not used, and the strains they might protect from are outdated. Politicians and public health experts have no plans to develop and stockpile a bird flu vaccine. A seasonal flu shot will not protect you from bird flu. 

Symptoms of H5N1 and H5N2 bird flu

The clinical presentation of both H5N1 and H5N2 bird flu are similar. Since the bird flu is mainly an infection of the respiratory system, symptoms in humans present like the seasonal flu, including cough, runny nose, sore throat, shortness of breath, body aches, headache, and a fever. Conjunctivitis, the reddening of the whites of the eyes, is common and is one of the primary symptoms of bird flu infection. Diarrhea and vomiting are also common. 

Typical Symptoms of the Bird Flu: 

• Red, irritated eyes
• Low-grade fever or no fever
• Sore, irritated throat
• Cough
• Headache
• Fatigue and malaise
• Achiness
• Diarrhea

Symptoms of the current strains of bird flu are like seasonal influenza. If you have flu-like symptoms but have no exposure to live poultry, you likely don’t have the bird flu. But if you have severe symptoms and have been near poultry or someone who has and who has symptoms, the only way to know for sure is to get tested. Influenza A, bird flu testing is performed from a fluid sample from eye or nose discharge or coughing up phlegm. 

Lab Tests for Influenza A and B: 

• Influenza A and B 
• Influenza A and B, and SARS-CoV-2 (COVID)
• Influenza A (N5) “bird flu” testing is taken from a fluid specimen collected from the conjunctiva or phlegm. 

Can antiviral drugs control bird flu infection?

Oseltamivir (Tamiflu) is the approved antiviral drug of choice recommended by the CDC and the WHO. The standard dose is 75 mg twice daily for 5 days. To be effective, you must take this antiviral within 2 days of confirmed infection and the start of symptoms. However, H5N1 avian influenza has circulated in Southeast Asia since the early 2000s. By 2006, patients had already shown drug resistance. 

The “backup” drug is baloxavir marboxil (Xofluza), which may have benefits even in the later stages of infection. It also is used to treat infected birds. Ivermectin is another drug used for bird flu. It was touted as a “cure” for SARS-CoV-2 infection during the COVID-19 Pandemic. But so far, studies haven’t found it effective for bird flu. 

How to Prevent and Beat the Bird Flu

The cornerstone of personal prevention is avoidance. If you don’t get exposed, you won’t get sick. Maintaining robust general health is the second key to beating the bird flu. Cornerstone lifestyle practices like a healthy diet, adequate sleep, and rest are essential, especially during the cold and flu seasons. Supporting your immune system with enough vitamin C, zinc, and selenium are foundational dietary supplements. 

• Avoid exposure
• Maintain health 
• Practice cornerstone healthy lifestyle and dietary principles
• Get enough rest and restorative sleep
• Take immune-supportive supplements

Vitamin C is a key supplement for viral immunity. Your white blood cells are the cornerstone cells of your immune system and require 100 times more vitamin C than the surrounding plasma and tissue. Vitamin C also promotes tissue repair after infection. 

Benefits of Vitamin C for Beating the Flu: 

• Indirect antiviral effect
• Improves viral immunity, the body’s immunological response to viral infection
• Anti-inflammatory effect
• Antioxidant protective effect on lung tissue
• Improves tissue repair and recovery

I wrote about the coming global viral pandemics in my books Viral Immunity and Beating the Flu. In these books, I provide detailed ways for preventing and beating the flu, including the bird flu. I’ve also written extensively on my website about ways to prevent and treat SARS-CoV-2 and how to manage Long COVID. 

Functional medicine practices like intravenous vitamin C have mixed reviews. Most studies haven’t proven vitamin C is effective for respiratory viral infections like influenza. However, a 2018 case study of one patient in Puerto Rico found it helpful. A 2023 meta-analysis found that vitamin C can reduce the severity of the common cold. My clinical experience with hundreds of patients getting IV vitamin C has shown they have fewer and milder infections and recover faster. I often recommend monthly IV vitamin C of 25 or 30 grams as a preventative treatment for my older patients. During cold and flu season, I prescribe weekly IV vitamin C treatments. The patients who get these IV drips have fewer infections; if they get sick, they recover faster.

4 Steps to Benefit from Supplements to Beat Bird Flu: 

1. Begin with the “Essential 2”: vitamin C and zinc. Start with the basic daily dose.
2. If there is flu activity in your area, or you work in healthcare with exposure to patients, take the prevention dose.  
3. At the first sign of symptoms, take the higher treatment dose. Don’t stop when your symptoms lessen. It’s common for respiratory infections to rebound. 
4. Continue the post-treatment dose for up to one month after your symptoms dissipate.  

Conclusion: The future of bird flu – surveillance, control efforts, and treatment strategies

Looking to the future, in an era where people are raising and eating more chickens and ducks worldwide, the threat of bird flu is a significant concern for global health and personal wellness. While scientific advances help to understand the virus and develop preventive measures, the potential for pandemic bird flu outbreaks continues to loom. The lessons learned from past viral outbreaks underscore the importance of vigilance, research, and international collaboration in combating avian influenza. 

The virus’s ongoing evolution necessitates adaptive strategies that can respond to emerging strains and changing epidemiological patterns. Governments, health organizations, and the poultry industry must work together to create resilient systems that can withstand the challenges posed by avian influenza.

Ultimately, the future of bird flu control efforts hinges on a commitment to global cooperation and a proactive approach to public health. However, we can better protect human and animal health in an increasingly interconnected world by fostering a culture of individual responsibility, preparedness and response, and effective self-care. 

While continued investment in surveillance, vaccination, and public awareness is essential for mitigating the global risks of bird flu, personal responsibility is the frontline of prevention and early treatment. 

The ongoing threat of bird flu reminds us of our shared commitment to safeguard global health and prevent the emergence of new pandemics. It calls for us to be better informed about viral immunity and armed with personal preventive and safe treatment measures to beat all types of influenza. 

Selected Resources

Briand F, Niqueux E, Brochet AL, Hars J, Jestin V. 2011. Unusual H5N2 Avian Influenza Virus Escapes Current Detection. J Clin Microbiol 49: https://doi.org/10.1128/jcm.00479-11

Cargnin Faccin F, Perez DR. Pandemic preparedness through vaccine development for avian influenza viruses. Hum Vaccin Immunother. 2024 Dec 31;20(1):2347019. Epub 2024 May 28. PMID: 38807261; PMCID: PMC11141480. https://doi.org/10.1080/21645515.2024.2347019   

Colunga Biancatelli, R. M. L., Berrill, M., & Marik, P. E. (2019). The antiviral properties of vitamin C. Expert Review of Anti-Infective Therapy, 18(2), 99–101. https://doi.org/10.1080/14787210.2020.1706483 

Gonzalez MJ et al (2018) High Dose Vitamin C and Influenza: A Case Report. J Orthomol Med. Volume 39(3). 

Granata, Guido, et al. (2024) Mortality of H5N1 human infections might be due to H5N1 virus pneumonia and could decrease by switching receptors: the Lancet Infectious Diseases, Volume 24, Issue 9, e544 – e545. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00460-2/fulltext 

Guan, W., Qu, R., Shen, L., Mai, K., Pan, W., Lin, Z., Chen, L., Dong, J., Zhang, J., Feng, P., Weng, Y., Yu, M., Guan, P., Zhou, J., Tu, C., Wu, X., Wang, Y., Yang, C., Ling, Y., . . . Yang, Z. (2024). Baloxavir marboxil is used for critical human infection of avian influenza A H5N6 virus. Med, 5(1), 32-41.e5. https://doi.org/10.1016/j.medj.2023.11.001 

Hemilä, H., Chalker, E. Vitamin C reduces the severity of common colds: a meta-analysis. BMC Public Health 23, 2468 (2023). https://doi.org/10.1186/s12889-023-17229-8 

Hoang, B. X., Shaw, G., Fang, W., & Han, B. (2020). Possible application of high-dose vitamin C in the prevention and therapy of coronavirus infection. Journal of Global Antimicrobial Resistance, 23, 256. https://doi.org/10.1016/j.jgar.2020.09.025 

Joob B, Wiwanitkit V. Human H5N2 bird flu infection: fact or fallacy? Asian Pac J Trop Biomed. 2014 May;4(Suppl 1):S49. /APJTB.4.2014C1202. PMID: 25183136; PMCID: PMC4025352.  https://doi:10.12980   

 Lycett, S. J., Duchatel, F., & Digard, P. (2019). A brief history of bird flu. Philosophical Transactions of the Royal Society B: Biological Sciences, 374(1775), 20180257. https://doi.org/10.1098/rstb.2018.0257 

Ramos, I., & Fernandez-Sesma, A. (2012). Innate Immunity to H5N1 Influenza Viruses in Humans. Viruses, 4(12), 3363. https://doi.org/10.3390/v4123363 

Shahbaz U, Fatima N, Basharat S, Bibi A, Yu X, Hussain MI, Nasrullah M. Role of vitamin C in preventinOVID-19 infection, progression and severity. AIMS Microbiol. 2022 Mar 30;8(1):108-124. https://doi:10.3934/microbiol.2022010.  

Sonnberg, S., Webby, R. J., & Webster, R. G. (2013). 2.1 Natural History of Highly Pathogenic Avian Influenza H5N1. Virus Research, 178(1), 10.1016/j.virusres.2013.05.009. https://doi.org/10.1016/j.virusres.2013.05.009

Taniguchi K, Ando Y, Kobayashi M, Toba S, Nobori H, Sanaki T, Noshi T, Kawai M, Yoshida R, Sato A, Shishido T, Naito A, Matsuno K, Okamatsu M, Sakoda Y, Kida H. Characterization of the In Vitro and In Vivo Efficacy of Baloxavir Marboxil against H5 Highly Pathogenic Avian Influenza Virus Infection. Viruses. 2022 Jan 8;14(1):111. https://doi:10.3390/v14010111 PMID: 35062315; PMCID: PMC8777714. 

Uyeki, Timothy M, Human Infection with Highly Pathogenic Avian Influenza A (H5N1) Virus: Review of Clinical Issues, Clinical Infectious Diseases, Volume 49, Issue 2, Jul 15, 2009, Pages 279–290, https://doi.org/10.1086/600035

Yamaji R, Saad MD, Davis CT, Swayne DE, Wang D, Wong FYK, McCauley JW, Peiris JSM, Webby RJ, Fouchier RAM, Kawaoka Y, Zhang W. Pandemic potential of highly pathogenic avian influenza clade 2.3.4.4 A(H5) viruses. Rev Med Virol. 2020 May;30(3):e2099. Epub 2020 Mar 5. PMID: 32135031; PMCID: PMC9285678. https://pubmed.ncbi.nlm.nih.gov/32135031/